These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 1382663

  • 1. Treatment of diffuse non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisolone and bleomycin (MACOP-B).
    Sawada U, Yamazaki T, Suzuki K, Ashiya M, Satou Y, Hirano H, Tsuboi I, Sakuma A, Kura Y, Kouda K.
    Int J Hematol; 1992 Aug; 56(1):59-66. PubMed ID: 1382663
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
    Pittrová H, Koza V, Vozobulová V, Cetkovský P, Skopek P, Jungerová J, Cepelák V.
    Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
    [Abstract] [Full Text] [Related]

  • 3. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
    Zinzani PL, Martelli M, Magagnoli M, Zaja F, Storti S, Pavone E, Lauta VM, De Renzo A, Gobbi M, Bocchia M, Ronconi F, Scaramucci L, Gherlinzoni F, Palombi F, Bendandi M, Stefoni V, Anticoli Borza P, Cellini C, Mandelli F, Tura S.
    Haematologica; 1999 Nov; 84(11):996-1001. PubMed ID: 10553159
    [Abstract] [Full Text] [Related]

  • 4. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, Gallo E, Ambrosetti A, Tecchio C, Tarella C, Gabbas A, Gallamini A, Gargantini L, Pizzuti M, Fioritoni G, Gottin L, Rossi G, Lazzarino M, Menestrina F, Paulli M, Palestro M, Cabras MG, Di Vito F, Pizzolo G.
    Br J Cancer; 2004 Jan 26; 90(2):372-6. PubMed ID: 14735179
    [Abstract] [Full Text] [Related]

  • 5. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR, Santini G, Chisesi T, Congiu AM, Rubagotti A, Contu A, Salvagno L, Coser P, Porcellini A, Vespignani M.
    J Clin Oncol; 1994 Jul 26; 12(7):1366-74. PubMed ID: 7517442
    [Abstract] [Full Text] [Related]

  • 6. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
    Hattori M, Motomura S, Tomita N, Taguchi J, Tanabe J, Sakai R, Fujisawa S, Fukawa H, Kanamori H, Mouri H, Maruta A, Kodama F, Okubo T.
    Rinsho Ketsueki; 1996 Feb 26; 37(2):101-8. PubMed ID: 8852026
    [Abstract] [Full Text] [Related]

  • 7. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
    Zinzani PL, Martelli M, Bendandi M, De Renzo A, Zaccaria A, Pavone E, Bocchia M, Falini B, Gobbi M, Gherlinzoni F, Stefoni V, Tani M, Tura S.
    Haematologica; 2001 Feb 26; 86(2):187-91. PubMed ID: 11224489
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 Feb 26; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 9. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug 26; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 10. MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?
    Mazza P, Bocchia M, Zanchini R, Gherlinzoni F, Zinzani PL, Pileri S, Tura S.
    Haematologica; 1991 Aug 26; 76(1):47-52. PubMed ID: 1711505
    [Abstract] [Full Text] [Related]

  • 11. MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.
    Tarella C, Gallo E, Ferrero D, Badoni R, Carlesso N, Caracciolo D, Pileri A.
    Haematologica; 1990 Aug 26; 75(2):149-54. PubMed ID: 1694155
    [Abstract] [Full Text] [Related]

  • 12. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
    Gopal R, Nair R, Saikia TK, Soman CS, Dinshaw KA, Advani SH.
    J Assoc Physicians India; 1994 Oct 26; 42(10):781-4. PubMed ID: 7533151
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T, Tóth E, Molnár Z, Várady E, Deák B, Horváth A, Horváth GI, Eid H, Schneider K, Lovey J, Keresztes S, Esik O, Lengyel Z, Rosta A.
    Orv Hetil; 2004 Dec 12; 145(50):2531-7. PubMed ID: 15662753
    [Abstract] [Full Text] [Related]

  • 14. [Bleomycin, adriamycin, cyclophosphamide, vincristine, deacadron, etoposide (BACOD-E) chemotherapy for the treatment of non-Hodgkin's lymphoma: long-term survival rate and complications].
    Isobe K, Yasuda S, Itami J, Hara R, Machida N, Aruga T, Uchida Y, Kuyama J, Yamamoto S, Kimura S, Motoori K, Ito H.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jun 12; 58(7):360-5. PubMed ID: 9711076
    [Abstract] [Full Text] [Related]

  • 15. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E.
    Haematologica; 2000 Mar 12; 85(3):263-8. PubMed ID: 10702814
    [Abstract] [Full Text] [Related]

  • 16. [Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination].
    Tada A, Ohnoshi T, Hayashi K, Ueoka H, Ueno K, Murashima M, Mizuta J, Yoshida M, Kimura I.
    Gan To Kagaku Ryoho; 1987 Sep 12; 14(9):2692-6. PubMed ID: 2443077
    [Abstract] [Full Text] [Related]

  • 17. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
    Gordon LI, Andersen J, Colgan J, Glick J, Resnick GD, O'Connell M, Cassileth PA.
    Cancer; 1995 Feb 01; 75(3):865-73. PubMed ID: 7530168
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC, Skarin AT, Rosenthal DS, MacIntyre JM, Pinkus GS, Case DC, Leonard RC, Canellos GP.
    Cancer Treat Rep; 1984 Nov 01; 68(11):1343-50. PubMed ID: 6209007
    [Abstract] [Full Text] [Related]

  • 19. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI.
    Semin Hematol; 1988 Apr 01; 25(2 Suppl 2):17-22. PubMed ID: 2456619
    [Abstract] [Full Text] [Related]

  • 20. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Sweetenham JW, Mead GM, Whitehouse JM.
    J Clin Oncol; 1991 Dec 01; 9(12):2202-9. PubMed ID: 1720454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.